South Africa Hemato Oncology Testing Market Size & Outlook
South Africa hemato oncology testing market, 2018-2028 (US$M)
Related Markets
South Africa hemato oncology testing market highlights
- The South Africa hemato oncology testing market generated a revenue of USD 27.6 million in 2020 and is expected to reach USD 69.5 million by 2028.
- The South Africa market is expected to grow at a CAGR of 12.2% from 2021 to 2028.
- In terms of segment, lymphoma was the largest revenue generating cancer type in 2020.
- Lymphoma is the most lucrative cancer type segment registering the fastest growth during the forecast period.
Hemato oncology testing market data book summary
| Market revenue in 2020 | USD 27.6 million |
| Market revenue in 2028 | USD 69.5 million |
| Growth rate | 12.2% (CAGR from 2020 to 2028) |
| Largest segment | Lymphoma |
| Fastest growing segment | Lymphoma |
| Historical data | 2018 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Leukemia, Lymphoma, MPNs, Other Cancers |
| Key market players worldwide | Roche Holding AG, Abbott Laboratories, Qiagen NV, Danaher Corp, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Illumina Inc, Bio-Techne Corp |
Other key industry trends
- In terms of revenue, South Africa accounted for 1.2% of the global hemato oncology testing market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Middle East & Africa, South Africa hemato oncology testing market is projected to lead the regional market in terms of revenue in 2028.
- South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 69.5 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hemato Oncology Testing Market Scope
Hemato Oncology Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa hemato oncology testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hemato oncology testing market will help companies and investors design strategic landscapes.
Lymphoma was the largest segment with a revenue share of 46.01% in 2020. Horizon Databook has segmented the South Africa hemato oncology testing market based on leukemia, lymphoma, mpns, other cancers covering the revenue growth of each sub-segment from 2018 to 2028.
South Africa is expected to show the lucrative growth rate in the MEA market. This can be attributed to the high prevalence of blood cancers and initiatives by various organizations for early diagnosis and treatment of blood cancer.
According to Globocan estimates, in 2020, around 3,769 new cases of nonHodgkin lymphoma, 2,027, new cases of leukemia, 1,294 new cases of multiple myeloma, and 712 new cases of Hodgkin lymphoma were diagnosed in South Africa.
Furthermore, nonprofit organizations such as CHOC Childhood Cancer Foundation provides comprehensive support to children’s suffering from blood cancers in the nine provinces of South Africa. However, factors such as low awareness about blood cancers, low access to advance testing solutions, less availability of skilled healthcare professionals & diagnostic laboratories may hinder the South Africa market growth over the forecast period.
Reasons to subscribe to South Africa hemato oncology testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa hemato oncology testing market databook
-
Our clientele includes a mix of hemato oncology testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa hemato oncology testing market , including forecasts for subscribers. This country databook contains high-level insights into South Africa hemato oncology testing market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa hemato oncology testing market size, by cancer type, 2018-2028 (US$M)
South Africa Hemato Oncology Testing Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
